Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference.
Saved in:
| Title: | Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference. |
|---|---|
| Authors: | Dallmann A; Bayer HealthCare SAS, Lille, France., Feick D; DMPK Modeling & Simulation, Sanofi R&D, Frankfurt am Main, Germany., Balazki P; ESQlabs GmbH, Saterland, Germany., Benamara S; Computational Pharmacology and Clinical Oncology, Inserm UMR1068, CNRS, Aix Marseille University, Marseille, France.; Translational Medicine & Early Development, Sanofi R&D, Vitry-sur-Seine, France., Burghaus R; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Chenel M; Pharmetheus AB, Uppsala, Sweden., Choi SL; DMPK Modeling & Simulation, Sanofi-Aventis R&D, Vitry-sur-Seine, France., Cordes H; DMPK Modeling & Simulation, Sanofi R&D, Frankfurt am Main, Germany., Guimarães M; ESQlabs GmbH, Saterland, Germany., Hamadeh A; School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada., Ince I; Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & co. KG, Ingelheim am Rhein, Germany., Job KM; Division of Clinical Pharmacology, Department of Pediatrics, School of Medicine, The University of Utah, Salt Lake City, Utah, USA., Kanacher T; Pharmetheus AB, Uppsala, Sweden., Kovar A; DMPK Modeling & Simulation, Sanofi R&D, Frankfurt am Main, Germany., Kuepfer L; Institute for Systems Medicine With Focus on Organ Interaction, University Hospital RWTH Aachen, Aachen, Germany., Lippert J; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Macente J; Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Nauwelaerts N; ESQlabs GmbH, Saterland, Germany.; Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Niederalt C; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Peters S; Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & co. KG, Ingelheim am Rhein, Germany., Proença S; ESQlabs GmbH, Saterland, Germany., Sato M; Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & co. KG, Ingelheim am Rhein, Germany., Schaller S; ESQlabs GmbH, Saterland, Germany., Schlender JF; Biomedical Research, Novartis, Basel, Switzerland., Schneider A; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Sjögren E; Pharmetheus AB, Uppsala, Sweden.; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden., Solodenko J; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Staab A; Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & co. KG, Ingelheim am Rhein, Germany., Vrenken P; National and Kapodistrian University of Athens, Department of Pharmacy, Zografou, Greece., Wendl T; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., de Witte WEA; ESQlabs GmbH, Saterland, Germany., Teutonico D; Translational Medicine & Early Development, Sanofi R&D, Vitry-sur-Seine, France. |
| Source: | CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2025 May; Vol. 14 (5), pp. 822-827. Date of Electronic Publication: 2025 Apr 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2163-8306 (Electronic) Linking ISSN: 21638306 NLM ISO Abbreviation: CPT Pharmacometrics Syst Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2163-8306 |
|---|---|
| DOI: | 10.1002/psp4.70028 |
